Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

6.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.1K
Drug-Receptor Interaction: Antagonist01:28

Drug-Receptor Interaction: Antagonist

2.8K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
2.8K
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance01:07

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance

34
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
34
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

621
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
621
Drug Discovery: Overview01:26

Drug Discovery: Overview

7.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.7K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

5.1K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

scDeepAPA: a deep learning framework for single-cell alternative polyadenylation identification.

Briefings in bioinformatics·2026
Same author

Beyond the canonical: The role of post-transcriptional regulation in drug-target interaction prediction.

PLoS computational biology·2026
Same author

Integrated Genomic and Epigenomic Analysis Reveals Epigenetic Plasticity in Disease Progression and Multidrug Resistance in Multiple Myeloma.

Cancer research·2026
Same author

X-intNMF: a cross- and intra-omics regularized NMF framework for multi-omics integration.

Bioinformatics (Oxford, England)·2026
Same author

DCGAT-DTI: dynamic cross-graph attention network for drug-target interaction prediction.

Bioinformatics advances·2026
Same author

SynOmics: integrating multi-omics data through feature interaction networks.

Briefings in bioinformatics·2025

Related Experiment Video

Updated: Jun 14, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.4K

DTI-LM: language model powered drug-target interaction prediction.

Khandakar Tanvir Ahmed1,2, Md Istiaq Ansari1,2, Wei Zhang1,2

  • 1Department of Computer Science, University of Central Florida, Orlando, FL 32816, United States.

Bioinformatics (Oxford, England)
|September 2, 2024
PubMed
Summary

DTI-LM, a new framework using language models, improves drug-target interaction predictions, especially for new proteins. It leverages sequence data and neighborhood information for enhanced accuracy in drug discovery.

More Related Videos

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.5K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.1K

Related Experiment Videos

Last Updated: Jun 14, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.4K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.5K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.1K

Area of Science:

  • Computational biology
  • Drug discovery and development
  • Bioinformatics

Background:

  • Drug-target interactions (DTIs) are crucial for drug discovery.
  • Sequence-based computational models offer efficient DTI prediction.
  • Cold start DTI prediction for unknown drugs or proteins remains a challenge.

Purpose of the Study:

  • To introduce DTI-LM, a novel framework for DTI prediction.
  • To leverage pretrained language models and neighborhood information for enhanced DTI prediction.
  • To bridge the gap between warm start and cold start DTI predictions using sequence representations.

Main Methods:

  • Utilized advanced pretrained language models for sequence representation of drugs and proteins.
  • Incorporated neighborhood information via a graph attention network.
  • Developed DTI-LM framework relying solely on sequence data.

Main Results:

  • DTI-LM achieved state-of-the-art performance on DTI prediction tasks across four datasets.
  • Demonstrated significant improvements in cold start predictions for proteins.
  • Observed a persistent disparity in cold start predictions between proteins and drugs.

Conclusions:

  • DTI-LM effectively predicts drug-target interactions using sequence-based language models.
  • The framework shows promise in addressing cold start challenges in DTI prediction.
  • Further research is needed to address the observed disparities in drug and protein cold start predictions.